Cargando…

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension

The BREELIB nebulizer was developed for iloprost to reduce inhalation times for patients with pulmonary arterial hypertension (PAH). This multicenter, randomized, unblinded, four-part study compared inhalation time, pharmacokinetics, and acute tolerability of iloprost 5 µg at mouthpiece delivered vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gessler, Tobias, Ghofrani, Hossein-Ardeschir, Held, Matthias, Klose, Hans, Leuchte, Hanno, Olschewski, Horst, Rosenkranz, Stephan, Fels, Lueder, Li, Na, Ren, Dawn, Kaiser, Andreas, Schultze-Mosgau, Marcus-Hillert, Müllinger, Bernhard, Rohde, Beate, Seeger, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467944/ https://www.ncbi.nlm.nih.gov/pubmed/28597762 http://dx.doi.org/10.1177/2045893217706691

Ejemplares similares

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

lloprost delivered via the BREELIB(TM) nebulizer: a review of the clinical evidence for efficacy and safety
por: Gessler, Tobias
Publicado: (2019)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
por: Schermuly, Ralph Theo, et al.
Publicado: (2005)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
por: Richter, Manuel J., et al.
Publicado: (2018)

The impact of nebulized epoprostenol and iloprost on hemoglobin oxygen affinity: an ex vivo experiment
por: Woyke, Simon, et al.
Publicado: (2022)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007)

The Use of an Inspiration-Synchronized Vibrating Mesh Nebulizer for Prolonged Inhalative Iloprost Administration in Mechanically Ventilated Patients—An In Vitro Model
por: Otto, Matthias, et al.
Publicado: (2023)

Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects
por: Adorni, Greta, et al.
Publicado: (2019)

Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
por: Jain, Pritesh P, et al.
Publicado: (2014)

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
por: Knudsen, Lars, et al.
Publicado: (2011)

Effect of Food Intake on the Pharmacokinetics of the Selective Progesterone Receptor Modulator Vilaprisan: A Randomized Clinical Study in Healthy Postmenopausal Women
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Characterization of aerosols containing Legionella generated upon nebulization
por: Allegra, Séverine, et al.
Publicado: (2016)

Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension
por: Mansour, Heidi M.
Publicado: (2018)

Viral Preservation with Protein-Supplemented Nebulizing Media in Aerosols
por: Humphrey, Brittany, et al.
Publicado: (2023)

Aerosolization Performance of Immunoglobulin G by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2023)

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women
por: Schütt, Barbara, et al.
Publicado: (2017)

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Aerosol-Containment Device for Prevention of Aerosol Dispersion During Nebulization in COVID-19 Patients
por: Kumar, Amarjeet, et al.
Publicado: (2021)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Acute Effects of Aerosolized Iloprost in COPD Related Pulmonary Hypertension - A Randomized Controlled Crossover Trial
por: Boeck, Lucas, et al.
Publicado: (2012)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2020)

Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Magnan, Marie-Anne, et al.
Publicado: (2021)

Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction
por: Egemnazarov, Bakytbek, et al.
Publicado: (2010)

Experimental Evaluation of Perfluorocarbon Aerosol Generation with Two Novel Nebulizer Prototypes
por: Aramendia, Iñigo, et al.
Publicado: (2019)

A novel mask to prevent aerosol spread during nebulization treatment
por: Kao, Chia-Lung, et al.
Publicado: (2021)

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women
por: Liu, Hongzhong, et al.
Publicado: (2020)

Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009)

Iloprost for COVID-19-related vasculopathy
por: Moezinia, Carine J, et al.
Publicado: (2020)

The Treatment of Pulmonary Diseases and Respiratory-Related Conditions with Inhaled (Nebulized or Aerosolized) Glutathione
por: Prousky, Jonathan
Publicado: (2008)

Exhaled Air and Aerosolized Droplet Dispersion During Application of a Jet Nebulizer
por: Hui, David S., et al.
Publicado: (2009)

Position of different nebulizer types for aerosol delivery in an adult model of mechanical ventilation
por: Hou, Haijia, et al.
Publicado: (2022)

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview
por: Schultze-Mosgau, Marcus-Hillert, et al.
Publicado: (2021)

Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform
por: Gerde, Per, et al.
Publicado: (2020)

Containment of procedure-associated aerosols by an extractor tent: effect on nebulized drug particle dispersal
por: Fennelly, M., et al.
Publicado: (2021)

Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Toussaint, Laura, et al.
Publicado: (2020)

Characterization and comparison of Re-Du-Ning aerosol particles generated by different jet nebulizers
por: Zhang, Yi, et al.
Publicado: (2019)

Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open‐label, single‐dose, parallel‐group study
por: Chattopadhyay, Niladri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sgg5m9eoo7v29f6elqlbac2hk1